Journals / Turkish Journal of Hematology / 2012 / Cilt: 29 - Sayı: 1

Tayland lı hemofili A hastalarında, HLA Sınıf II alleleri ve faktör VIII inhibitör oluşumunun ilişkisi

Association of HLA class II alleles and the occurrence of factor VIII inhibitor in Thai patients with hemophilia A

Pages
34–39
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The study s findings show that the DRB1*15 allele might have contributed to the occurrence of inhibitor in the Thai hemophilia A patients; however, additional research using larger samples and high-resolution DRB1 typing is warranted.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to investigate the association between HLA class II alleles and the occurrence of FVIII inhibitor in Thai hemophilia A patients.
📊
Key Findings & Data:Material and Methods: The distribution of HLA-DRB1 alleles and DQB1 alleles in 57 Thai hemophilia A patients and 36 blood donors as controls was determined using the PCR sequence-specific primer (PCR-SSP) method, and the association between the occurrence of factor VIII (FVIII) inhibitor and the presence of certain HLA class II alleles was investigated.
💡
Conclusion & Impact:Conclusion: The study s findings show that the DRB1*15 allele might have contributed to the occurrence of inhibitor in the Thai hemophilia A patients; however, additional research using larger samples and high-resolution DRB1 typing is warranted.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to investigate the association between HLA class II alleles and the occurrence of FVIII inhibitor in Thai hemophilia A patients. Material and Methods: The distribution of HLA-DRB1 alleles and DQB1 alleles in 57 Thai hemophilia A patients and 36 blood donors as controls was determined using the PCR sequence-specific primer (PCR-SSP) method, and the association between the occurrence of factor VIII (FVIII) inhibitor and the presence of certain HLA class II alleles was investigated. Results: The frequency of HLA-DRB1*15 was higher in the hemophilia A patients with and without FVIII inhibitor, whereas that of DRB1*14, DRB1*07, and DQB1*02 was lower in the hemophilia A patients with FVIII inhibitor, as compared to controls. Interestingly, only the frequency of DRB1*15 was significantly higher in the patients with inhibitor than in the controls (P = 0.021). Moreover, the frequency of DRB1*15 in the patients with inhibitor was higher than in those without inhibitor (P = 0.198). Conclusion: The study s findings show that the DRB1*15 allele might have contributed to the occurrence of inhibitor in the Thai hemophilia A patients; however, additional research using larger samples and high-resolution DRB1 typing is warranted.

Özet

Amaç: Bu çalışmada HLA sınıf II allelleri hemofili A ile Taylandlı hastalarda FVIII inhibitörü oluşumu ile ilişkiyi araştırmaktır. Gereç ve Yöntemler: Hemofili 57 Taylandlı hastalarda HLA-DRB1 allelleri ve DQB1 allel dağılımı bir PCR-sıra özel astar (PCR-SSP) yöntemi ve faktör VIII (FVIII) inhibitör oluşumu arasındaki ilişki kullanılarak belirlendi ve bazı HLA klas II allelleri varlığı araştırılmıştır. Bulgular: HLA-DRB1 sıklığı * 15 ve FVIII inhibitörü olmayan iki hemofili hastalarında artmış iken DRB1 olanlar * 14, DRB1 * 07 ve DQB1 * 02 FVIII inhibitörleri ile hemofili hastalarında azalmıştı. İlginçtir, sadece DRB1 * 15 önemli kontrol (P = 0.021) ile karşılaştırıldığında inhibitörleri olan hastalarda artmıştır. Ayrıca, inhibitörü olan hastalarda DRB1 * 15 frekans olmayan inhibitörü (P = 0.198) olan hastalarda daha yüksek olma eğiliminde. Sonuç: Bulgularımız DRB1 * 15 allel Tay hemofili A hastalarında inhibitör oluşumuna katkıda bulunabileceğini göstermiştir. Ancak, daha büyük bir örneklem büyüklüğü ve yüksek çözünürlüklü DRB1 yazarak garantilidir.

🔖

Cite This Article

NATHALANG, O., SRIWANITCHRAK, P., SASANAKUL, W., CHUANSUMRIT, A. (2012). Tayland lı hemofili A hastalarında, HLA Sınıf II alleleri ve faktör VIII inhibitör oluşumunun ilişkisi. Turkish Journal of Hematology, Cilt: 29 - Sayı: 1, 34–39. https://ajindex.com/articles/412608

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wight J, Paisley S: The epidemiology of inhibitors in haemophilia A: A systemic review. Haemophilia 2003
  2. 435 2.Addiego J, Kasper C, Abildgaard C, Hilgartner M, Lusher J, Glader B, Aledort L: Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII. Lancet 1993
  3. 464 3.Mahasandana C, Patharathienskul D, Suvatte V: Hemophilia with factor VIII and IX inhibitors, incidence, bleeding problems and management. Southeast Asian J Trop Med Public Health 1993
  4. 24 (Suppl1): 106-112 4.Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G 3rd, Lee M: A multicenter study of recombinant factor VIII (Recombinate): Safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group. Blood 1994
  5. 2435 5.De Biasi R, Rocino A, Papa ML, Salerno E, Mastrullo L, De Blasi D: Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates. Thromb Haemost 1994
  6. 547 6.Kavakli K, Gringeri A, Bader R, Nisil G, Polat A, Aydinok Y: Inhibitor development and substitution therapy in a developing country: Turkey. Haemophilia 1998
  7. 108 7.Wight J, Paisley S: The epidemiology of inhibitors in haemophilia A: A systematic review. Haemophilia 2003
  8. 435 8.Oldenburg J, Picard JK, Schwaab R, Brackmann HH, Tuddenham EG, Simpson E: HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII. Thromb Haemost 1997
  9. 242 9.Hay CR, Ollier W, Pepper L, Cumming A, Keeney S, Goodeve AC, Colvin BT, Hill FG, Preston FE, Peake IR: HLA class II profile: A weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party. Thromb Haemost 1997
  10. 237 10.Pavlova A, Zeitler H, Scharrer I, Brackmann HH, Oldenburg J: HLA genotype in patients with acquired haemophilia A. Haemophilia 2010
  11. 112 11.Kasper CK, Aledort LM, Counts RB: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975
  12. 872 12.Rossetti LC, Radic CP, Larripa IB, De Brasi CD: Developing a new generation of tests for genotyping hemophilia-causative rearrangements involving int 22 h and int 1 h hotspots in the factor VIII gene. J Thromb Haemost 2008
  13. 836 13.Rossetti LC, Radic CP, Larripa IB, De Brasi CD: Genotyping the hemophilia inversion hotspot by use of inverse P